PLoS ONE · 2015 · 57 citations · 29 references
MedicineNeurosciencePharmacologyMolecular PharmacologyNeuropharmacologyPharmacodynamicsAnalgesic PharmacologyGastrointestinal PharmacologyGastrointestinal PhysiologyIrritable Bowel SyndromeOpioid AnalgesicsOpioid PharmacologyAnalgesic Drug MechanismsAnimal Disease ModelsAnticancer ActivityDelta Opioid Receptor PharmacologyIntestinal Motility InhibitionIrritable Bowel Syndrome PathophysiologyMurine ModelsVisceral Pain Relief
BACKGROUND AND AIMS: Berberine and its derivatives display potent analgesic, anti-inflammatory and anticancer activity. Here we aimed at characterizing the mechanism of action of berberine in the gastrointestinal (GI) tract and cortical neurons using animal models and in vitro tests. METHODS: The effect of berberine was characterized in murine models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms. Then the opioid antagonists were used to identify the receptors involved. Furthermore, the effect of berberineon opioid receptors expression was established in the mouse intestine and rat fetal cortical neurons. RESULTS: In mouse models, berberine prolonged GI transit and time to diarrhea in a dose-dependent manner, and significantly reduced visceral pain. In physiological conditions the effects of berberine were mediated by mu- (MOR) and delta- (DOR) opioid receptors; hypermotility, excessive secretion and nociception were reversed by berberine through MOR and DOR-dependent action. We also found that berberine increased the expression of MOR and DOR in the mouse bowel and rat fetal cortical neurons. CONCLUSION: Berberine significantly improved IBS-D symptoms in animal models, possibly through mu- and delta- opioid receptors. Berberine may become a new drug candidate for the successful treatment of IBS-D in clinical conditions.
29
Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain
Grégory Scherrer, Noritaka Imamachi, Yuqing Cao et al. · Cell · 2009 · 452 citations · Full text
Medicine, Neurobiology, Pharmacology +16
Chunfen Mo, Ling Wang, Jie Zhang et al. · Antioxidants and Redox Signaling · 2013 · 438 citations · Full text
Facilitation of μ-Opioid Receptor Activity by Preventing δ-Opioid Receptor-Mediated Codegradation
Shao-Qiu He, Zhen‐Ning Zhang, Ji‐Song Guan et al. · Neuron · 2011 · 231 citations · Full text
Medicine, Neuroscience, Pharmacology +14
Pravinkumar Bhutada, Yogita Mundhada, Kuldeep Bansod et al. · Behavioural Brain Research · 2011 · 206 citations
Medicine, Neuroscience, Pharmacology +15